Episode 72 - Nick Manusos - CEO of Kenai Therapeutics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/e4/1e/d5e41e47-bfe8-20ea-325b-c4cfd91dca77/mza_4324065226824686757.jpg/600x600bb.jpg

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

91 episodes

5 days ago

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.

Life Sciences

Science

RSS

All content for The BioHub: The Top Voices in Biotech is the property of Max Brennan - Biotech HeadHunter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1704904841978-1a5f9097fe03.jpg

Episode 72 - Nick Manusos - CEO of Kenai Therapeutics

The BioHub: The Top Voices in Biotech

26 minutes 1 second

1 week ago

Episode 72 - Nick Manusos - CEO of Kenai Therapeutics

Welcome back to another episode of The BioHub, we weredelighted to welcome on Nick Manusos, the CEO of Kenai Therapeutics, a pioneering biotech company developing neuron replacement therapies for neurological disorders. Nick’s journey spans decades of innovation and leadership—from senior roles at global pharma giants like Baxter, Takeda, and Abbott, to founding and leading cutting-edge startups like Iota Biosciences and Opsis Therapeutics. Under his guidance, Kenai Therapeutics has secured groundbreaking funding and is advancing life-changing therapies for patientswith Parkinson’s disease. He holds an MBA from Northwestern University’s

Kellogg School of Management and a BBA from the University of Wisconsin, bringing a rare combination of business acumen and scientific vision to the table. Nick joins us today to share his insights on pioneering stem celltherapies, building biotech startups from the ground up, and what it takes to turn cutting-edge science into real-world solutions.